Anticancer Effect of New Cannabinoids Derived from Tetrahydrocannabinolic Acid on PANC-1 and AsPC-1 Human Pancreas Tumor Cells.

Journal of Pancreatic Cancer Pub Date : 2020-06-09 eCollection Date: 2020-01-01 DOI:10.1089/pancan.2020.0003
Alexander Aizikovich
{"title":"Anticancer Effect of New Cannabinoids Derived from Tetrahydrocannabinolic Acid on PANC-1 and AsPC-1 Human Pancreas Tumor Cells.","authors":"Alexander Aizikovich","doi":"10.1089/pancan.2020.0003","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> New tetrahydrocannabinolic acid (THCA) derivatives ALAM027 and ALAM108 were proposed for the treatment of the pancreatic cancer disease. <b>Methods:</b> The <i>in vitro</i> effect of new cannabinoids ALAM027 and ALAM108 was tested against PANC-1 and AsPC-1 cell lines by CellTiter Glo assay. Pancreatic cancer xenograft model was used for the <i>in vivo</i> anticancer activity study of these compounds on PANC-1 cells. <b>Results:</b> The <i>in vitro</i> study of new cannabinoids showed greater activity of ALAM108 than ALAM027 both for PANC-1 and AsPC-1 cells. The <i>in vivo</i> study of new cannabinoids on PANC-1 cells showed that their oral administration was effective in reducing tumor volume and tumor weight, and did not lead to any discomfort and weight loss of mice. <b>Conclusion:</b> The cannabinoids ALAM108 and ALAM027 inhibited the tumor growing 1.6-2 times in mice with human PANC-1 cells.</p>","PeriodicalId":16655,"journal":{"name":"Journal of Pancreatic Cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/pancan.2020.0003","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pancreatic Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/pancan.2020.0003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Purpose: New tetrahydrocannabinolic acid (THCA) derivatives ALAM027 and ALAM108 were proposed for the treatment of the pancreatic cancer disease. Methods: The in vitro effect of new cannabinoids ALAM027 and ALAM108 was tested against PANC-1 and AsPC-1 cell lines by CellTiter Glo assay. Pancreatic cancer xenograft model was used for the in vivo anticancer activity study of these compounds on PANC-1 cells. Results: The in vitro study of new cannabinoids showed greater activity of ALAM108 than ALAM027 both for PANC-1 and AsPC-1 cells. The in vivo study of new cannabinoids on PANC-1 cells showed that their oral administration was effective in reducing tumor volume and tumor weight, and did not lead to any discomfort and weight loss of mice. Conclusion: The cannabinoids ALAM108 and ALAM027 inhibited the tumor growing 1.6-2 times in mice with human PANC-1 cells.

Abstract Image

Abstract Image

Abstract Image

四氢大麻酚酸衍生的新型大麻素对人胰腺肿瘤细胞PANC-1和AsPC-1的抗癌作用
目的:提出新的四氢大麻酚酸(THCA)衍生物ALAM027和ALAM108用于治疗胰腺癌。方法:采用CellTiter Glo法检测新型大麻素ALAM027和ALAM108对PANC-1和AsPC-1细胞株的体外作用。采用胰腺癌异种移植模型,研究这些化合物对PANC-1细胞的体内抗癌活性。结果:新型大麻素体外研究显示,ALAM108对PANC-1和AsPC-1细胞的活性均高于ALAM027。新型大麻素对PANC-1细胞的体内研究表明,口服大麻素可有效减小肿瘤体积和肿瘤重量,且不引起小鼠不适和体重减轻。结论:大麻素ALAM108和ALAM027对人PANC-1细胞小鼠肿瘤生长的抑制作用为1.6 ~ 2倍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信